We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Q&A Guidance on Inspections, Drug Applications During Pandemic
FDA Issues Q&A Guidance on Inspections, Drug Applications During Pandemic
The FDA has released a question-and-answer guidance to clarify its policies on inspections, pending drug applications and changes in manufacturing facilities for approved drug products during the COVID-19 pandemic.